CPhI has released the findings of its 2017 India Pharma Market Report, identifying improved international repute of India but an urgent call for government support for investment in active pharmaceutical ingredient (API) facilities.
India
The report highlights a two-tier manufacturing market in the country and predicts that acquisitions by Indian companies will increase. However, the opinion of the respondents was that more investment by the government needs to be made in API sites.